These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8228158)

  • 41. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment with beta-lactam antibiotics in skin and soft tissue infections.
    Hedström SA
    Scand J Infect Dis Suppl; 1984; 42():135-42. PubMed ID: 6597559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A model for calculating costs of hospital-acquired infections: an Italian experience.
    Gianino MM; Vallino A; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
    J Health Organ Manag; 2007; 21(1):39-53. PubMed ID: 17455811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Criteria-based antimicrobial i.v. to oral conversion program.
    Okpara AU; Maswoswe JJ; Stewart K
    Formulary; 1995 Jun; 30(6):343-8. PubMed ID: 10144873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
    Amara S; Adamson RT; Lew I; Huang X
    Curr Med Res Opin; 2013 Jul; 29(7):869-77. PubMed ID: 23659559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.
    Suleyman G; Kenney R; Zervos MJ; Weinmann A
    J Clin Pharm Ther; 2017 Feb; 42(1):39-43. PubMed ID: 27747899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology and economics of adult patients hospitalized with urinary tract infections.
    Cardwell SM; Crandon JL; Nicolau DP; McClure MH; Nailor MD
    Hosp Pract (1995); 2016; 44(1):33-40. PubMed ID: 26673518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
    Bazaz R; Chapman AL; Winstanley TG
    J Antimicrob Chemother; 2010 Jul; 65(7):1510-3. PubMed ID: 20460397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy.
    Rhew DC; Hackner D; Henderson L; Ellrodt AG; Weingarten SR
    Chest; 1998 Jan; 113(1):142-6. PubMed ID: 9440581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dosage cefepime as treatment for serious bacterial infections.
    Giamarellou H
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():123-32. PubMed ID: 8150755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of bacterial skin and soft tissue infections.
    File TM; Tan JS
    Surg Gynecol Obstet; 1991; 172 Suppl():17-24. PubMed ID: 2024222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of acute uncomplicated urinary tract infection in adults.
    Hooton TM; Stam WE
    Med Clin North Am; 1991 Mar; 75(2):339-57. PubMed ID: 1996038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of laboratory reports on prescribing of antimicrobials for urinary tract infection.
    Barnes MP
    J Clin Pathol; 1980 May; 33(5):481-3. PubMed ID: 7400346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors predictive of inappropriateness in requests for parenteral antimicrobials for therapeutic purposes: a study in a small teaching hospital in Brazil.
    Kawanami GH; Fortaleza CM
    Scand J Infect Dis; 2011 Jul; 43(6-7):528-35. PubMed ID: 21401329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic evaluation of oral ofloxacin versus standard parenteral therapy in the treatment of pneumonia.
    Menzin J; Huse DM; Richner R; Oster G
    Pharmacoeconomics; 1992 Aug; 2(2):171-7. PubMed ID: 10146956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of Outpatient and Inpatient Antibiotic Treatment Patterns and Health Care Costs of Patients with Complicated Urinary Tract Infections.
    Turner RM; Wu B; Lawrence K; Hackett J; Karve S; Tunceli O
    Clin Ther; 2015 Sep; 37(9):2037-47. PubMed ID: 26212569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
    Shah PJ; Bergman SJ; Graham DR; Glenn S
    J Pharm Pract; 2015 Oct; 28(5):462-8. PubMed ID: 25107418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicenter, phase IV evaluation of intravenous ciprofloxacin as initial therapy in patients with lower respiratory tract, urinary tract, and skin/skin structure infections.
    Pankey GA
    Clin Ther; 1995; 17(3):353-65. PubMed ID: 7585840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters.
    Huang WC; Wann SR; Lin SL; Kunin CM; Kung MH; Lin CH; Hsu CW; Liu CP; Lee SS; Liu YC; Lai KH; Lin TW
    Infect Control Hosp Epidemiol; 2004 Nov; 25(11):974-8. PubMed ID: 15566033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.
    Heintz BH; Halilovic J; Christensen CL
    Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.